Immunohistochemical changes in vulnerable rat brain regions after reversible global brain ischaemia

Journal of Molecular Histology

Volumn 38, Issue 4, 2007, Pages 295-302

  Martinez, Giuseppa ^a   Musumeci, Giuseppe ^a   Loreto, Carla ^a   Carnazza, Maria Luisa ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Apoptosis; Bax; Bcl 2; MMP 9; Post ischaemic reperfused brain; Reversible global ischaemia

Indexed keywords

DNA FRAGMENT; GELATINASE B; PROTEIN BAX; PROTEIN BCL 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN REGION; CELL DEATH; CEREBELLUM CORTEX; CONTROLLED STUDY; DENTATE GYRUS; DOWN REGULATION; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MORPHOLOGY; NERVE CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; REPERFUSION; SIMULATION;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; BRAIN ISCHEMIA; DNA FRAGMENTATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; REPERFUSION INJURY; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

RATTUS;

EID: 34547103505     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-007-9102-9     Document Type: Article

References (32)

1. Aoki T, Sumii T, Mori T, Wang X, Lo EH (2002) Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneosly hypertensive rats. Stroke 33:2711-2717
2. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung HF, Colburn NH, Sun Y (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP-3). Carcinogenesis 17:1805-1811
3. Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, Gearing AJ (1997) Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72:155-161
4. Crèange A, Sharshar T, Planchenault T, Christov C, Poron F, Raphael JC, Gherardi RK (1999) Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barrè syndrome. Neurology 53:1683-1691
5. Fata JE, Leco KJ, Voura EB, Yu HE, Waterrhouse P, Murphy G, Moorehead R A, Khokha R (2001) Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 108:831-841
6. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA (2002) S-nitrosylation of matrix metalloproteinase: signaling pathway to neuronal cell death. Science 297:1186-1190
7. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, Rosenberg GA, Lo EH, Moskowitz MA (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447-1455
8. Huppertz B, Kaufmann HGFP (1999) The apoptosis cascade-morphological and immunohistochemical methods for its visualization. Anat Embryol 200:1-18
9. Jaworski DM, Fager N (2000) Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) m RNA expression during rat CNS development. J Neurosci Res 61:396-408
10. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A, Planas AM (2003) Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 23:1430-1440
11. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigations of the subcellular distribution of the Bcl-2 oncoprotein residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membrane. Cancer Res 53:4701-4714
12. Lam M, Dubyak G, Chen L, Nujez G, Miesfeld RL, Distelhorst CW (1994) Evidence that Bcl-2 represses apoptosis by regulating endoplasmic reticulum associated Ca2+ fluxes. Proc Natl Acad Sci USA 91:6569-6573
13. Lee SR, Tsuji K, Lee SR, Lo EH (2004) Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 21:671-678
14. Lo EH, Wang X, Cuzner ML (2002) Extracellular proteolysis in brain injury and inflammation: role for plasminogen activation and matrix metalloproteinase. J Neurosci Res 69:1-9
15. Longa EZ, Weinstein PR, Carlson S, Cummis R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91
16. Maier CM, Hsieh L, Yu F, Bracci P, Chan PH (2004) Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immumohistochemistry in a model of transient focal cerebral ischemia. Stroke 35:1169-1174
17. Magnoni S, Baker A, George SJ, Duncan WC, Kerr LE, McCulloch J, Horsburgh K (2004) Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol Dis 17:188-197
18. Martinez G, Carnazza ML, Giacomo CD, Sorrenti V, Castana R, Pennini G, Perez-Polo JR, Vanella A (1996) Neuronal lesions and behavioral modifications in rat following cerebral ischemia and reperfusion. Neurochem Res 21:667-674
19. Noll F (1984) Methods of Enzymatic Analysis. In: Bergmeyer HU (ed), vol 6. Ferlag, Chemie-Weinheim-Germany, pp 582-588
20. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL (1998) Differential expression of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729-741
21. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP (1992) A new inhibitor of metalloproteinases from chicken: ChTimp-3. A third member of the TIMP family. J Biol Chem 267:17321-17326
22. Planas AM, Sole S, Justica C (2001) Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 8:834-846
23. Qiu HG, Dong SP, Xiao ML, Xiao TW, Tian LX, Guang YZ (2006) Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Dev Brain Res 1092:36-46
24. Rink AD, Fung KM, Trojanowski JQ, Lee VMY, Neugebauer E, McIntosh TK (1995) Evidence of apoptosis cell death after experimental traumatic brain injury in the rat. Am J Pathol 147:1575-1583
25. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020-1030
26. Szklarczyk A, Lapinska J, Rylski M, Mckay RDG, Kaczmarek L (2002) Matrix metalloproteinase-9 undergoes expression and activation during dentritict remodeling in adult hippocampus. J Neurosci 22:920-930
27. Thierry AM, Gioanni Y, Degenetais E, Glowinski J (2000) Iippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 10:411-419
28. Yong VW, Krekoski CA, Forsyth P, Edward DR (1998) Matrix Metalloproteinases and disease of the CNS. Trends. Neurosci 21:75-80
29. Weisz DJ, Clark GA, Thompson RF (1984) Increased responsivity of dentate granule cells during nictitating membrane response conditioning in rabbit. Bahav Brain Res 12:145-154
30. Wetzel M, Rosenberg GA, Cunningham LA (2003) Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinases-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 18:1050-1060
31. Wiskott L, Rasch M, Kempermann G (2006) A functional hypothesis for adult hippocampal neurogenesis: avoidance of catastrophic interference in the dentate gyrus. Hippocampus 16:329-343
32. Zhao BQ, Ikeda Y, Ihara H, Urano T, Fan W, Mikawa S, Suzuki Y, Kondo K, Sato K, Nagai N, Umemura K (2004) Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice. Blood 103:2610-2616